‘Cutting-edge' supercomputing facility, a $2.8B investment, planned for Spartanburg County
Interior of a modern data center. A proposed $2.8 billion 'computing center' in South Carolina's Upstate would have its own onsite power generation. (Stock photo)
A national investment firm has pledged to open a $2.8 billion computing center in South Carolina's Upstate.
NorthMark Strategies inked a deal with Spartanburg County to bring its supercomputing operations to a former Kohler manufacturing plant and warehouse.
'Of the more than 100 locations across the country we considered, Spartanburg stood out for its strong community, skilled workforce, dynamic economy and strategic advantages,' NorthMark Strategies President Jen Byrne said in a statement. 'Our investment in this high-performance computing center solidifies our commitment to building for future growth and being prepared to meet the growing demand for (high performance computing) capabilities.'
The company plans to transform the facility into 'one of the most advanced (high performance computing) facilities in the world, leveraging cutting-edge technology to support complex computational tasks in machine learning, data analytics, and complex systems modeling.'
A $2.8B computing center proposed in the Upstate would generate its own electricity
The project, previously referred to publicly as 'Project Moc-1' while the deal was negotiated, comes as South Carolina grapples with how to meet the energy needs of a growing population, manufacturing base and an influx of power heavy data centers.
These data centers, housing rows of servers, are focused on the storage of vast amount of data. High performance computing, on the other hand, is about analyzing large amounts of data, which would cause a typical computer to freeze up, at high speeds.
It can do this multiple ways, either with the use of a custom-built supercomputer or a cluster of individual computers all working together, to give the user more computing power than a standard, single computer. North Carolina State University, for example, offers one such cluster.
NorthMark's clients turn to the company with their complex engineering problems. NorthMark's computing centers power the company's various simulation and artificial intelligence tools that its clients can use to design and troubleshoot whatever they need.
'We don't just fund ideas — we help test, refine, and improve them,' according to NorthMark's website.
'With NorthMark Strategies establishing operations in Spartanburg County, South Carolina continues to add to its already impressive technology industry. We celebrate this remarkable investment in the Upstate and all it will mean for our state and our people,' Secretary of Commerce Harry Lightsey said in a statement.
NorthMark's center will be different from massive centers under construction by Google and Facebook parent company Meta in a second way.
Those centers each require hundreds of megawatts to operate.
But NorthMark will connect to a nearby natural gas pipeline and use the fuel to make its own power, County Councilman David Britt previously told the SC Daily Gazette. The center is not expected to use more energy than the site's former tenant, Kohler, which closed in 2024 after 66 years.
While the reported investment figure is immense — the second largest single investment in state history — the company will employ just 27 full-time workers. NorthMark has not disclosed what these jobs will be or the potential salary for these positions.
$15M effort to train SC students on supercomputers starts at USC
To lure in the company, Spartanburg County offered a reduced property tax rate of 4% for 40 years.
By state law, manufacturers without such an arrangement pay a 6% rate. (Industrial property owners previously paid a 10.5% rate, but state laws passed in 2017 and 2022 effectively lowered it to 6%.)
The county also is offering special credits allowing the company to further buy down its tax bill — a $1.5 million annual credit for the first 20 years and $2 million for the 20 years after that.
NorthMark is not seeking any tax incentives or grants from the state, according to a company spokeswoman.
The company is renovating the facility in three phases, starting with a 350,000-square-foot former warehouse on site and ending with the former 500,000-square-foot manufacturing plant.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
FinReg and CPA.com's alliance targets US
FinReg Global Solutions and have partnered to launch QMCore platform in the US, targeting a market of 18,000 audit and accounting companies. FinReg is an Irish innovator in RegTech, while is the business and technology arm of the American Institute of Certified Public Accountants (AICPA). QMCore is a quality management platform specifically designed for audit firms. This collaboration signifies a notable achievement for FinReg, providing access to a vast market comprising more than 46,000 accounting and audit firms across the US. FinReg is the first Irish enterprise to attain Preferred Partner status with QMCore aims to support audit firms in adapting to changing regulatory requirements, including SQMS No. 1 and QC 1000. Created in Dublin, this adaptable, cloud-based solution streamlines compliance processes and boosts operational efficiency for its clients. The platform delivers a unified system for conducting risk assessments, delegating responsibilities, and maintaining thorough audit trails. This capability is intended to alleviate the administrative challenges that audit firms encounter in their compliance activities. Through Preferred Partner Programme, QMCore will be accessible to a network of 18,000 firms. Established in 2017, FinReg is located in Sandyford Industrial Estate, Dublin, and caters to various sectors, including professional services and healthcare. FinReg Global CEO David Butler said: 'We are delighted with this long-term strategic partnership and it is a great outcome for us to have QMCore recognised as the preferred provider of a quality solution for an organisation such as 'The partnership reflects our commitment to delivering compliance-driven innovation that empowers firms to meet the demands of modern regulation.' "FinReg and alliance targets US" was originally created and published by The Accountant, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
ENYO Pharma Announces Completion of Series C Financing With Vesalius Biocapital and Continued Progress of Its ALPESTRIA-1 Clinical Phase 2 Study in Alport Syndrome Patients
LYON, France--(BUSINESS WIRE)--ENYO Pharma ('ENYO'), a clinical-stage biotechnology company focused on developing FXR agonists for the treatment of severe kidney diseases, today announced the smooth continuation of its Phase 2 ALPESTRIA-1 trial in 26 Alport syndrome patients. The topline results from the trial are on track for the fourth quarter of 2025. In parallel, ENYO has finalized its Series C financing round with a €6 million investment from Vesalius Biocapital IV, bringing the total Series C raise to €32 million. The ongoing ALPESTRIA-1 study evaluates Vonafexor, a highly selective and oral FXR agonist, in patients with Alport syndrome, a rare genetic kidney disease with no approved therapy. The trial involves a 24-week ascending doses regimen followed by a 12-week off-treatment observation period. ALPESTRIA-1 was launched mid 2024 in 4 countries (US, F, SP and D) following Orphan Drug Designation from both the FDA and EMA. The new funding from Vesalius Biocapital IV extends ENYO's cash runway through the second half of 2026 and enables the initiation of two new clinical programs: A proof-of-concept trial in patients with Chronic Kidney Disease (CKD) grade 3 and concurrent F2/F3 MASH, building on the promising renal results from the previous Phase 2 LIVIFY clinical study; A PK/PD head-to-head comparison of Vonafexor and its analog EYP651 in healthy subjects. In addition, ENYO will continue to expand its preclinical portfolio, notably in Autosomal Dominant Polycystic Kidney Disease (ADPKD), where the Vonafexor franchise could offer a novel and disease-modifying approach. ' We are pleased with the continued progress of ALPESTRIA-1 and honored to welcome Vesalius Biocapital to our investor syndicate and Dr. Jean-Christophe Renondin as new Board member,' said Dr. Jacky Vonderscher, CEO of ENYO. ' This additional investment will allow us to accelerate the development of our FXR agonist pipeline in both rare and more prevalent kidney diseases. We share a common belief with Vesalius in the transformative potential of Vonafexor and EYP651 for patients suffering from inflammation- and fibrosis-driven renal conditions.' ' Vesalius Biocapital is excited to support ENYO as it progresses into the next phase of clinical development for Vonafexor and its analog EYP651, ' commented Dr. Jean-Christophe Renondin, Managing Partner at Vesalius Biocapital IV. ' There is an immense need for new treatments in kidney conditions such as Alport Syndrome and CKD. We believe Vonafexor has the potential to help these patients and make a meaningful impact on their lives. I look forward to working with ENYO's excellent leadership team to advance this promising therapeutic candidate.' About ENYO Pharma: ENYO is a clinical-stage biopharmaceutical company headquartered in Lyon (France) and developing proprietary drug candidates to improve quality of life and avoid end stage renal disease and dialysis/transplantation for patients with rare and common kidney diseases. Since its inception ENYO collected extensive phase I/II clinical data through nine completed clinical studies with ca. 400 subjects. ENYO is supported by a strong syndicate of global investors: OrbiMed, Morningside, AndEra, BPIFrance (InnoBio and Large Venture), Sofinnova Partners and Vesalius). For more information: ENYO Pharma About Vesalius Biocapital: Vesalius is a specialist life sciences venture capital investor, investing in companies in later stage companies in drug development, medical device diagnostic and e-health since 2007. Vesalius Biocapital IV, launched in June 2023, targets first and best-in-class European life science companies in drug development and digital health. Its investment portfolio is well balanced between drug development and non-drug development investments and committed to providing capital to science-backed innovation and ambitious entrepreneurs. The team is based in Europe to explore investment opportunities and valuation potential for the portfolio. Managing Partners include Guy Geldhof, Dr Jean-Christophe Renondin and Stéphane Verdood.
Yahoo
12 hours ago
- Yahoo
New Details On F/A-18 Super Hornet's Troubled IRST Pod
More details have emerged about the problems the U.S. Navy is facing with its ill-starred podded Infrared Search And Track system, or IRST, an important capability planned for its F/A-18E/F Super Hornet fighters. The latest issues to be highlighted come after TWZ previously reported on delays caused by production quality problems with the system and a Pentagon assessment of 'significant reliability problems during operational testing,' which emerged earlier this year. The latest status update on the ASG-34A(V)1 IRST pod is provided in the Weapon Systems Annual Assessment that was published today by the Government Accountability Office (GAO). The centerline-mounted IRST pod is intended to provide the F/A-18E/F with a long-wave infrared sensor — the Lockheed Martin-developed IRST21 — that can search, detect, and track airborne targets. Very importantly, it is an ideal tool for detecting stealthy targets, which are proliferating. The IRST sensor assembly is installed in the front portion of a redesigned FPU-13/A centerline fuel tank. According to the GAO, each pod costs $16.6 million. For the full background on the pod, you can read our interview with the Super Hornet program manager responsible for it, back in 2020, here. The GAO report notes that, although the IRST pod achieved initial capability on schedule in November 2024, including delivery of the first lot of low-rate initial production pods, a full-rate production decision has been delayed. At one point, a determination on full-rate production was planned for January 2025, but this was missed 'due to delays incurred during flight testing.' As a result, the program has now breached its baseline schedule for the second time in three years. 'IRST officials told us that operational tests were delayed by two months due to software defects that caused IRST pods to falsely report overheating,' the GAO notes. Director, Operational Test and Evaluation (DOT&E) officials told the GAO that the problem 'was relatively easy to fix and would likely have been addressed during developmental testing had the program allocated more time for that testing.' Thanks to those operational testing delays, the publication of the DOT&E report that informs the full-rate decision production slipped until March 2025. A corresponding decision is now expected sometime this month. Until then, the program is somewhat in limbo, although it has achieved some good results, notably demonstrating 'capability at tactically significant ranges during operational testing.' This has been tempered, however, by how often the pods failed during that same testing. DOT&E officials told the GAO that the pods were 'extremely unreliable.' While we previously knew of issues with reliability, today's report confirms just how bad these are. Although 'the program improved pod reliability as it made software updates, [it] only managed to achieve 14 hours mean time between operational mission failures — short of the 40 hours required.' Not surprisingly, the DOT&E determined that deploying the IRST pods without improving their reliability would transfer risk to the Navy's fleet. Of course, this is bad news for the Navy, and for the F/A-18E/F community specifically, with IRST sensors — which can detect and track objects from a distance and in environments where radar may be ineffective — is increasingly seen as a vital air combat tool. Seemingly ever since it was first flown on a Super Hornet in late 2019, the IRST pod has faced issues. A previous GAO report, in 2023, noted that 'between 20 and 30 percent of the manufactured components [in the IRST pod] failed to meet performance specifications due to microelectronics issues.' These problems persisted more than four years after limited manufacturing had begun and served to delay the launch of developmental and operational testing. The same 2023 report also described how 'staffing challenges' at a critical software development contractor were leading to holdups in the program. Then came a DOT&E report, which looked at the results of tests involving Infrared Optimized Configuration (IROC) pods, described as 'operationally equivalent' but designated for flight test. IROC pods were used for operational test and evaluation (IOT&E) between April and September 2024. This report noted that 'operational test events were adversely affected by IRST Block II system reliability failures' and concluded that the pod 'demonstrated significant reliability problems.' 'Throughout the test period, IRST Block II suffered from hardware and software deficiencies, which required the aircrew to restart the pod multiple times,' the DOT&E report said. 'Troubleshooting and repair often exceeded the abilities of Navy maintenance crews and required assistance from Lockheed Martin.' In the meantime, however, earlier iterations of the pod have already been deployed on operations, carried by Super Hornets in the Middle East, with photos emerging of this appearing in late 2020. As the Navy awaits the decision on whether or not to pursue full-rate production, there's no doubt about the utility of an IRST pod — provided that it works. The specific advantages of the IRST pod are something we have discussed before, including with the Super Hornet program manager: 'Very importantly, the IRST pod provides an entirely passive capability, relying exclusively on the infrared spectrum to detect and track airborne targets, including those at far beyond visual range. With no radio-frequency emissions, the target won't be alerted to the fact that they've been detected and are being tracked. At the same time, the IRST does not give away the location and presence of the host platform. This kind of sensor also provides a vital companion to the Super Hornet's AN/APG-79 radar, functions of which may well be compromised in a heavy electronic attack or radar-denied environment.' Meanwhile, similar kinds of sensors have been found on fighters operated by potential adversaries for decades. China and Russia operate tactical fighters such as the Su-35 and Su-30 Flanker series that incorporate IRST sensors as standard. In Western Europe, the Eurofighter Typhoon and Saab Gripen E, for example, also offer them. Closer to home, the U.S. Air Force has already put equivalent sensors on its F-15Cs and F-16Cs, making the delays to the Navy's program all the more puzzling. On the other hand, we don't know exactly how reliable the Air Force's IRST pods are, and we do know that there are substantial differences between the Air Force and Navy versions, although they both use IRST21 as a base the fact that a functioning IRST capability can be integrated on even older platforms without too much difficulty is also evidenced in the contractor-operated adversary community, which is increasingly flying fast jets with IRST sensors to better replicate potential threat aircraft. On the other hand, it should be recalled that not all IRST sensors offer the same level of capabilities, with significant differences also in terms of depth of integration and fusion between different types and aircraft, especially over time. This applies especially to the higher-end IRST pod for the Super Hornet and some of the cheaper off-the-shelf options that are now available. Threat aircraft with IRST capabilities continue to proliferate, but so do the kinds of threat platforms for which a sensor of this kind would be most useful to counter. China, especially, is making rapid developments in stealth technology and advanced electronic warfare, two areas that make the introduction of an IRST sensor all the more compelling. These kinds of infrared sensors are immune to radar-evading stealth technology and are not affected by electromagnetic jamming and other electronic attacks. For Navy Super Hornets, a fully functional ISRT pod would help to detect and target advanced Chinese platforms in a future conflict in the Pacific theater. At the same time, these pods can significantly boost the flight crew's situational air-to-air 'picture' in conjunction with more traditional sensors. As noted previously, there has been some good news with the latest iteration of the IRST pod, specifically the fact that it has, in a test environment, demonstrated that it can detect targets at long ranges. Furthermore, it can translate this data into stable system tracks that would be suitable for weapons employment. With its clear potential, it's certainly alarming for the Navy that it is still being kept waiting for the vital capabilities promised by the IRST pod. Contact the author: thomas@
